Source: Eur Respir J 2006; 27: 248-249
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hamid Q.. How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies?. Eur Respir J 2006; 27: 248-249

Member's Comments

No comment yet.

Related content which might interest you: Do measures of bronchial responsiveness add information in diagnosis and monitoring of patients with asthma? Source: Eur Respir J 2001; 18: 439-441 Year: 2001 A proposal for standardization of the bronchial biopsy assessment in severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 Eosinophils in bronchial biopsy predict functional response to biological therapy in severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007 Clinical relevance of small airways assessment by lung function tests in asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis Source: International Congress 2016 – COPD diagnosis and management Year: 2016 The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 Bronchial biopsy can not be recommended to discriminate asthma and COPD in routine practice Source: Eur Respir J 2003; 22: Suppl. 45, 413s Year: 2003 Why inflammatory phenotyping is necessary for successful drug evaluation in asthma and COPD Source: Eur Respir J 2013; 42: 891-892 Year: 2013 Infectional factors influences on cytomorphological picture of bronchial biopsies at COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 735s Year: 2006 Infectional factors influences on cytomorphological picture of bronchial biopsies at COPD exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Bronchial thermoplasty for the treatment of asthma patientswith COPD characteristics: an exploratory histopathological evaluation. Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Bronchial biopsies in clinical asthma research - problems and pitfalls Source: Annual Congress 2003 - Bronchial biopsies in clinical asthma research - problems and pitfalls Year: 2003 Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001